We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Polarean Imaging Plc | POLX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.05 | -2.67% | 1.825 | 12:51:05 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.875 | 1.825 | 1.90 | 1.825 | 1.875 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 10/7/2024 19:06 by slicethepie Unlike your Sce investment this company has a product that is transformational, has industry investors, a committed board that has put their own money into the recent raise. Chalk and cheese! |
Posted at 03/7/2024 20:29 by goldbutler Communication with shareholders according to annual report - proactive -shareholders events in london?Communication with Shareholders The Board is committed to maintaining good communication and having constructive dialogue with its shareholders in order to maintain good investor relations and seeks, wherever possible to attain a relationship of mutual understanding with both institutional and private client investors. As such, Polarean takes a proactive approach to investor relations initiatives with ongoing support from Walbrook PR Limited, the Group’s financial PR advisors. These investor relations initiatives include (but are not limited to): l shareholder events in London and elsewhere; l the use of social media, in accordance with the Group’s Social Media Policy, and the Company’s website; and l interviews with platforms such as Proactive Investors around key developments |
Posted at 28/6/2024 14:05 by goldbutler The directors of this company have ruined the share price since FDA approval and they view shareholders not sitting on the Board as of no importance.This CEO and Chairman could quite easily switch a video web cam on for the AGM - it was done throughout Covid by other companies - but they don't. They have utter contempt for UK investors. |
Posted at 28/6/2024 11:42 by goldbutler The resignation of not one but three directors is not good.No mention of new appointments such as David Newlands is not good news for UK retail investors. |
Posted at 27/6/2024 14:04 by goldbutler Babbler talking utter nonsense keep up to dateThey Board of Directors or IR/PR haven't updated the investor relations They haven't announced AGM date for 2024 7 September was last years interims and the AGM was 28 June 2023 The following amendment has been made to the Half year Report announcement released on 7 September 2023 at 07.00am under RNS No: 6338L 28 Jun 2023 03:00 PM RNS Result of AGM |
Posted at 27/6/2024 13:42 by babbler Results are due September as per their investor relations date on their website. AGM tomorrow. Now stop scare mongering.https://ww |
Posted at 27/6/2024 11:48 by goldbutler UK investors including II's & Asset and Fund managers should be pushing for Boardroom changes in this company |
Posted at 25/6/2024 14:14 by mirabeau Yes, plenty of cash now, FDA secured product and some properly decent partners and investors... |
Posted at 22/5/2024 08:03 by bones698 That's John sat on a 25% loss already on top of all his other losses. See what I meanWashing machine your another clueless investor who doesn't have a clue. Like I said watch and learn although it's probably beyond your comprehension And FYI I was a bear on AGL for many years but it amazes me how many investors are u bale to adapt and see change for what it is. I've made plenty on AGL which not many can say. I also expect I will make a lot more too. I won't invest in this because it's just a shockingly bad business. Even at 1p. Take a look at sce instead far better chance of recovery than this |
Posted at 04/4/2024 12:31 by goldbutler The Board of Directors including Bracco representative director and Nukemsaid that 9 conversions were planned for 2 years wave 1 and wave 2 Wholly inadequate for the company survival funded by 27 million pounds and more from AIM investors On a monthly basis 28 people receive a very handsome pay cheque and the CEO cannot bring himself to refer to shareholders He never stops on Linkedin including references to a previous company So where is the investor presentaion for AIM INVESTORS for wave 1 and 2 Wave 1 Wave 2 Ohio Texas Missouri Iowa N.Carolina Kansas Virginia Illinois Wisconsin Where is the commercial strategy including partnerships for sales into UK and Europe and arab states where there is no shortage of cash and significant COPD problem. Why would any board of directors behave like this and for 18 months warn and advise of a cash raise and see the share price destruction. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
